Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan Jul 2016 Int J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia Jul 2016 J Pediatr Hematol Oncol aplastic anemia
Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients Jul 2016 Haematologica aplastic anemia
Paroxysmal Nocturnal Hemoglobinuria: The Future Of Complement-Based Therapies Jul 2016 Curr Drug Targets paroxysmal nocturnal hemoglobinuria (PNH)
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts Jul 2016 Br J Haematol myelodysplastic syndromes (MDS)
A Comparison of Outcomes for Cord Blood Transplant and Unrelated Bone Marrow Transplant in Adult Aplastic Anemia Jul 2016 Biol Blood Marrow Transplant aplastic anemia
Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study Jul 2016 Int J Hematol aplastic anemia
Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes Jun 2016 Hematology myelodysplastic syndromes (MDS)
Long Day's Journey Into Night for Lower-Risk Myelodysplastic Syndromes Jun 2016 J Clin Oncol myelodysplastic syndromes (MDS)
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents Jun 2016 J Clin Oncol myelodysplastic syndromes (MDS)